Brief: Living Cell Technologies Undertakes A$2.5 Mln Capital Raise Initiative
28/02/2023 21:20
March 1 (Reuters) - Living Cell Technologies Ltd
LCT.AX :
* LCT UNDERTAKES A$2.5 MILLION CAPITAL RAISE INITIATIVE
* ALSO INTENDS TO COMPLETE A NON-RENOUNCEABLE RIGHTS ISSUE
ENTITLEMENT OFFER
* RIGHTS ISSUE OFFER AT ONE NEW SHARE IN CO FOR EVERY EIGHT
SHARES
HELD
Source text for Eikon: ID:nASXVKhB8
Further company coverage: LCT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsBrief: Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent Pharma
Brief: Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement
Brief: Algorae Pharmaceuticals Raises A$3.9 Million At A$0.012 Per Share
Brief: Algorae Pharmaceuticals Says TGA Accepts Initial Registration Dossier For Evaluation
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre For Second AI-Driven Drug Synergy Screening Program